Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 551	$ 152
Trade accounts and other receivables (net of allowance of $6 at June 30, 2023 and December 31, 2022)	1,362	2,723
Inventories	259	320
Derivative assets	233	323
Other current assets and deferred charges	234	279
Total current assets	2,639	3,797
Investments	5,046	5,065
Property, plant, and equipment	50,240	47,057
Accumulated depreciation and amortization	(17,894)	(16,168)
Property, plant, and equipment – net	32,346	30,889
Intangible assets – net of accumulated amortization	7,573	7,363
Regulatory assets, deferred charges, and other	1,421	1,319
Total assets	49,025	48,433
Current liabilities:
Accounts payable	1,146	2,327
Derivative liabilities	143	316
Accrued and other current liabilities	1,218	1,270
Commercial paper	0	350
Long-term debt due within one year	2,877	627
Total current liabilities	5,384	4,890
Long-term debt	21,532	21,927
Deferred income tax liabilities	3,325	2,887
Regulatory liabilities, deferred income, and other	4,575	4,684
Contingent liabilities and commitments (Note 9)
Stockholders’ equity:
Preferred stock ($1 par value; 30 million shares authorized at June 30, 2023 and December 31, 2022; 35,000 shares issued at June 30, 2023 and December 31, 2022)	35	35
Common stock ($1 par value; 1,470 million shares authorized at June 30, 2023 and December 31, 2022; 1,256 million shares issued at June 30, 2023 and 1,253 million shares issued at December 31, 2022)	1,256	1,253
Capital in excess of par value	24,538	24,542
Retained deficit	(12,982)	(13,271)
Accumulated other comprehensive income (loss)	12	(24)
Treasury stock, at cost (39 million shares at June 30, 2023 and 35 million shares at December 31, 2022 of common stock)	(1,180)	(1,050)
Total stockholders’ equity	11,679	11,485
Noncontrolling interests in consolidated subsidiaries	2,530	2,560
Total equity	14,209	14,045
Total liabilities and equity	$ 49,025	$ 48,433